middle.news
How Argenica’s ARG-007 Shows Promise for High-Risk Stroke Patients
9:43am on Wednesday 3rd of September, 2025 AEST
•
Healthcare
Read Story
How Argenica’s ARG-007 Shows Promise for High-Risk Stroke Patients
9:43am on Wednesday 3rd of September, 2025 AEST
Key Points
ARG-007 demonstrated safety with no significant adverse events versus placebo
No drug interactions found with standard clot-dissolving therapies
Overall efficacy endpoint not met due to variability in infarct volumes
15% infarct volume reduction observed in high-risk subgroup with slow collateral flow
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
AGN
OPEN ARTICLE